Biofrontera

(NASDAQ) BFRI

Current Price$0.93

Market Cap$11.97M

Since IPO (2021)-99%

5 YearN/A

1 Year+56%

1 Month-18%

Biofrontera Financials at a Glance

Market Cap

$11.97M

Revenue (TTM)

$43.20M

Net Income (TTM)

-$11.09M

EPS (TTM)

-$1.11

P/E Ratio

-0.84

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.93

Volume

205,518.051

Open

$0.99

Price

$0.93

Volume

205,518.051

Open

$0.99

Previous Close

$0.94

Daily Range

$0.92 - $1.00

52-Week Range

$0.55 - $1.19

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.93

Volume

205,518.051

Open

$0.99

Previous Close

$0.94

Daily Range

$0.92 - $1.00

52-Week Range

$0.55 - $1.19

Estimated Earnings Date

Aug 12, 2026

BFRI News

Biofrontera Q2 Revenue Jumps 15%

Motley Fool Markets TeamAug 14, 2025

Biofrontera Revenue Jumps 15% in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biofrontera

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Hermann Lübbert, PhD

Website

www.biofrontera-us.com

Headquarters

Woburn, MA 01801, US

BFRI Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

-21%

Net Income Margin

-26%

Return on Equity

-339%

Return on Capital

-64%

Return on Assets

-45%

Earnings Yield

-1.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.97M

Shares Outstanding

12.80M

Volume

205.52K

Avg. Volume

177.21K

Financials (TTM)

Gross Profit

$32.80M

Operating Income

-$9.15M

EBITDA

-$8.28M

Operating Cash Flow

-$13.36M

Capital Expenditure

-$2.00K

Free Cash Flow

-$13.36M

Cash & ST Invst.

$6.39M

Total Debt

$6.16M

Biofrontera Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$10.08M

+17.4%

Gross Profit

$8.25M

+56.0%

Gross Margin

81.84%

N/A

Market Cap

$11.97M

N/A

Market Cap/Employee

$130.12K

N/A

Employees

N/A

Net Income

-$4.75M

-13.1%

EBITDA

-$4.32M

+0.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$1.41M

+54.2%

Accounts Receivable

$3.88M

-3.8%

Inventory

$1.23M

-81.1%

Long Term Debt

$7.22M

+62.7%

Short Term Debt

$506.00K

+18.8%

Return on Assets

-44.72%

N/A

Return on Invested Capital

-64.33%

N/A

Free Cash Flow

-$75.00K

+98.2%

Operating Cash Flow

-$70.00K

+98.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

COCPCocrystal Pharma, Inc.

COCPCocrystal Pharma, Inc.$0.96-8.16%

TRIBTrinity Biotech plc

TRIBTrinity Biotech plc$0.67-2.43%

AYTUAytu BioPharma, Inc.

AYTUAytu BioPharma, Inc.$2.25+5.89%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.62+1.53%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.06-1.90%

GELSGelteq Limited Ordinary Shares

GELSGelteq Limited Ordinary Shares$0.50-3.31%

SNSESensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.$14.65-11.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About BFRI

What is the current price of Biofrontera?

Biofrontera is trading at $0.94 per share.

What is the 52-week range for Biofrontera?

Over the past 52 weeks, Biofrontera has traded between $0.55 and $1.19.

How much debt does Biofrontera have?

As of the most recent reporting period, Biofrontera reported total debt of $7.72M.

How much cash does Biofrontera have on hand?

Biofrontera reported $6.32M in cash and cash equivalents in its most recent financial results.

What is Biofrontera’s dividend yield?

Biofrontera does not currently have a dividend yield.

Biofrontera

Biofrontera Financials at a Glance

BFRI News

Biofrontera Q2 Revenue Jumps 15%

Biofrontera Revenue Jumps 15% in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biofrontera

BFRI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biofrontera Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BFRI

What is the current price of Biofrontera?

What is the 52-week range for Biofrontera?

How much debt does Biofrontera have?

How much cash does Biofrontera have on hand?

What is Biofrontera’s dividend yield?

Premium Investing Services